Paras Healthcare IPO Listing Price, GMP History

IPO overview

The clinical specialty-led healthcare network operates a platform delivering tertiary and quaternary medical treatments across northern regions. Market positioning centers on accessible and high-acuity care delivery throughout targeted states.

About the company

The enterprise functions through a collective footprint of eight medical facilities holding an aggregate capacity of 2,211 beds as of mid-2026. Clinical operations span Haryana, Bihar, Uttar Pradesh, Rajasthan, Jharkhand, and the union territory of Jammu and Kashmir under the established trade identity. Core medical disciplines emphasize specialized therapeutic categories including cardiac care, oncology, neurology, gastrointestinal sciences, orthopedics, sports injury, and renal treatments. Facilities are situated in cities such as Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar. Long-term lease agreements support ongoing geographical expansion, including planned units in Gurugram and Ludhiana.

IPO structure and use of proceeds

Proceeds from the portion involving selling shareholders will accrue directly to those participants after accounting for relevant expenses and taxes, yielding no primary capital inflow to the issuer from that segment. Fresh issue allocations are designated for debt prepayment or scheduled repayment obligations, funding the wholly owned subsidiary Plus Medicare Hospitals Private Limited for similar debt servicing requirements, and addressing general corporate needs.

Key strengths and risks

Participation involves exposure to high degrees of risk as detailed within official disclosure documents. Prospective participants must evaluate uncertainties tied to lease-dependent facility scaling, regional market dynamics, and regulatory compliance associated with healthcare operations across multiple states and union territories.

Company background source: Paras Healthcare — company information · Checked 15 Oct 2026. This source covers the business description; GMP is an unofficial indication.